Cardiovascular Medicine

6059 KB

Open AccessArticle

Korrigendum

by

Cardiovasc. Med. 1998, 1(2), 170; https://doi.org/10.3390/cardiovascmed1020038 - 30 Aug 1998

Viewed by 120

Abstract

abstract Full article

18832 KB

Open AccessArticle

Fortbildungsveranstaltungen

by

Cardiovasc. Med. 1998, 1(2), 168-170; https://doi.org/10.3390/cardiovascmed1020037 - 30 Aug 1998

Viewed by 159

Abstract

abstract Full article

12889 KB

Open AccessArticle

Jahresbericht 1997 der Arbeitsgruppe Herzschrittmacher und Elektrophysiologie

by M. Fromer

Cardiovasc. Med. 1998, 1(2), 166-167; https://doi.org/10.3390/cardiovascmed1020036 - 30 Aug 1998

Viewed by 140

Abstract

abstract Full article

51342 KB

Open AccessProceeding Paper

Current Concepts in Cerebrovascular Prevention

by A. Dewarrat and J. Bogousslavsky

Cardiovasc. Med. 1998, 1(2), 158-165; https://doi.org/10.3390/cardiovascmed1020035 - 30 Aug 1998

Viewed by 142

Abstract

abstract Full article

39614 KB

Open AccessProceeding Paper

Treatment of Acute Ischaemic Stroke

by H.P. Mattie

Cardiovasc. Med. 1998, 1(2), 151-157; https://doi.org/10.3390/cardiovascmed1020034 - 30 Aug 1998

Viewed by 128

Abstract

abstract Full article

45077 KB

Open AccessProceeding Paper

Clinical Pathophysiology of Ischemic Stroke

by Vuadens J. Bogousslavsky

Cardiovasc. Med. 1998, 1(2), 143-150; https://doi.org/10.3390/cardiovascmed1020033 - 30 Aug 1998

Viewed by 312

Abstract

abstract Full article

► Show Figures

Figure 1

33340 KB

Open AccessProceeding Paper

Peripheral Artery Disease and Diabetes Mellitus

by D. Hayoz

Cardiovasc. Med. 1998, 1(2), 137-142; https://doi.org/10.3390/cardiovascmed1020032 - 30 Aug 1998

Viewed by 208

Abstract

abstract Full article

► Show Figures

Figure 1

38925 KB

Open AccessProceeding Paper

New Trends in Treatment of Coronary Artery Disease

by D. Atar

Cardiovasc. Med. 1998, 1(2), 131-136; https://doi.org/10.3390/cardiovascmed1020031 - 30 Aug 1998

Viewed by 448

Abstract

abstract Full article

► Show Figures

Figure 1

34562 KB

Open AccessProceeding Paper

Coronary Artery Disease: Pathophysiology

by Philip Urban

Cardiovasc. Med. 1998, 1(2), 125-129; https://doi.org/10.3390/cardiovascmed1020030 - 30 Aug 1998

Viewed by 266

Abstract

abstract Full article

► Show Figures

Figure 1

46064 KB

Open AccessProceeding Paper

Pathogenesis of Atherosclerosis: A Possible Relation to Infection

by Georg Noll

Cardiovasc. Med. 1998, 1(2), 117-124; https://doi.org/10.3390/cardiovascmed1020029 - 30 Aug 1998

Viewed by 289

Abstract

Full article

► Show Figures

Figure 1

34213 KB

Open AccessProceeding Paper

Platelet Inhibitory Drugs: Present Status and New Developments

by J. H. Beer and B. J. Meyer

Cardiovasc. Med. 1998, 1(2), 111-116; https://doi.org/10.3390/cardiovascmed1020028 - 30 Aug 1998

Viewed by 193

Abstract

For many years, aspirin has set the standard for platelet inhibition in cardiovascular prophylaxis and therapy. With the advent of newer, invasive techniques and new potent antiplatelet agents, antiplatelet therapy will be likely to change and diversify in the near future. This brief [...] Read more.

For many years, aspirin has set the standard for platelet inhibition in cardiovascular prophylaxis and therapy. With the advent of newer, invasive techniques and new potent antiplatelet agents, antiplatelet therapy will be likely to change and diversify in the near future. This brief review summarises present and future developments. Essentially, two trends are crystallizing: (a) the combination of established antiplatelet agents such as aspirin with ticlopidin or newly with others such as clopidogrel and (b) the platelet glycoprotein 11b/IIIa antagonists in their different, optimized molecular forms and dosages. Full article

► Show Figures

Figure 1

54884 KB

Open AccessProceeding Paper

Platelet Activation—Clinical Implications

by J. M. Clemetson and K. J. Clemetson

Cardiovasc. Med. 1998, 1(2), 102-110; https://doi.org/10.3390/cardiovascmed1020027 - 30 Aug 1998

Viewed by 359

Abstract

Platelets play a vital role in the maintainance of vascular integrity in health as well as in disease. However, in addition they are now suspected to have a wide range of other functions and to be involved in the origins and development of [...] Read more.

Platelets play a vital role in the maintainance of vascular integrity in health as well as in disease. However, in addition they are now suspected to have a wide range of other functions and to be involved in the origins and development of several disease states. Platelet activation is necessary for physiological function but the delicate balance regulating the threshhold for activation and the reversal of activation can be disturbed by many factors. A better understanding of these factors and the ability to control platelet activity by a range of recently developed inhibitors should reduce the impact of platelet-related disorders. Nevertheless, there is much that is still unclear about the part played by platelets in the origins of cardiovascular diseases. Full article

► Show Figures

Figure 1

27839 KB

Open AccessProceeding Paper

Epidemiological Considerations on Cardiovascular Diseases: Trends in Cardiac and Cerebrovascular Mortality in Switzerland

by U. Ackermann-Liebrich, E. Zemp Stutz and M. Züllig

Cardiovasc. Med. 1998, 1(2), 97-101; https://doi.org/10.3390/cardiovascmed1020026 - 30 Aug 1998

Viewed by 167

Abstract

abstract Full article

► Show Figures

Figure 1

5407 KB

Open AccessEditorial

Editorial

by J. Bogousslavsky

Cardiovasc. Med. 1998, 1(2), 95; https://doi.org/10.3390/cardiovascmed1020025 - 30 Aug 1998

Viewed by 110

Abstract

abstract Full article

12578 KB

Open AccessEditorial

Editorial

by D. Atar and T. F. Lüscher

Cardiovasc. Med. 1998, 1(2), 93-94; https://doi.org/10.3390/cardiovascmed1020024 - 30 Aug 1998

Viewed by 156

Abstract

abstract Full article

► Show Figures

Figure 1

Journal Menu

Journal Browser

Cardiovasc. Med., Volume 1, Issue 2 (08 1998) – 15 articles , Pages 93-170

Further Information

Guidelines

MDPI Initiatives

Follow MDPI